Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).

A Calgary clinic has received provisional accreditation to provide a novel way of administering the psychedelic drug ketamine ...

Ketamine has received a Hollywood makeover. It used to be known as a rave drug (street name special K) and cat anesthetic.

IntroductionMajor depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing ...

Ketamine, a non-competitive N-methyl-D-aspartate receptor antagonist, has emerged as an effective therapeutic agent for the management of treatment-resistant depression. Repeated treatments with ...

Ketamine has received a Hollywood makeover. It used to be known as a rave drug (street name special K) and cat anesthetic. However, in recent years, some doctors have prescribed ketamine to treat ...

New research sheds light on how ketamine affects the brain by targeting a specific NMDA receptor subtype, GluN1-2B-2D.

The drug is approved for use by doctors and veterinarians as an anesthetic—but is also capable of producing hallucinogenic ...

We’re with Dr. Handoo, one of the most experienced psychiatrists in the country for treatment-resistant depression. He ...

A Hollywood Tragedy,' which focuses on a criminal investigation and charges brought after the actor’s death in October 2023.